Literature DB >> 11381103

Natural biology of polyomavirus middle T antigen.

K A Gottlieb1, L P Villarreal.   

Abstract

"It has been commented by someone that 'polyoma' is an adjective composed of a prefix and suffix, with no root between--a meatless linguistic sandwich" (C. J. Dawe). The very name "polyomavirus" is a vague mantel: a name given before our understanding of these viral agents was clear but implying a clear tumor life-style, as noted by the late C. J. Dawe. However, polyomavirus are not by nature tumor-inducing agents. Since it is the purpose of this review to consider the natural function of middle T antigen (MT), encoded by one of the seemingly crucial transforming genes of polyomavirus, we will reconsider and redefine the virus and its MT gene in the context of its natural biology and function. This review was motivated by our recent in vivo analysis of MT function. Using intranasal inoculation of adult SCID mice, we have shown that polyomavirus can replicate with an MT lacking all functions associated with transformation to similar levels to wild-type virus. These observations, along with an almost indistinguishable replication of all MT mutants with respect to wild-type viruses in adult competent mice, illustrate that MT can have a play subtle role in acute replication and persistence. The most notable effect of MT mutants was in infections of newborns, indicating that polyomavirus may be highly adapted to replication in newborn lungs. It is from this context that our current understanding of this well-studied virus and gene is presented.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11381103      PMCID: PMC99028          DOI: 10.1128/MMBR.65.2.288-318.2001

Source DB:  PubMed          Journal:  Microbiol Mol Biol Rev        ISSN: 1092-2172            Impact factor:   11.056


  385 in total

1.  The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors.

Authors:  A J Ridley; A Hall
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

2.  A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA.

Authors:  J D Marth; R Peet; E G Krebs; R M Perlmutter
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

3.  Association of protein phosphatase 2A with polyoma virus medium tumor antigen.

Authors:  G Walter; R Ruediger; C Slaughter; M Mumby
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Genetic and structural analysis of a virulence determinant in polyomavirus VP1.

Authors:  P H Bauer; R T Bronson; S C Fung; R Freund; T Stehle; S C Harrison; T L Benjamin
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

5.  The roles of individual polyoma virus early proteins in oncogenic transformation.

Authors:  M Rassoulzadegan; A Cowie; A Carr; N Glaichenhaus; R Kamen; F Cuzin
Journal:  Nature       Date:  1982-12-23       Impact factor: 49.962

6.  Serum, AP-1 and Ets-1 stimulate the human ets-1 promoter.

Authors:  M A Majérus; F Bibollet-Ruche; J B Telliez; B Wasylyk; B Bailleul
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

7.  Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src.

Authors:  J E Thomas; A Aguzzi; P Soriano; E F Wagner; J S Brugge
Journal:  Oncogene       Date:  1993-09       Impact factor: 9.867

8.  tkl is the avian homolog of the mammalian lck tyrosine protein kinase gene.

Authors:  L M Chow; M J Ratcliffe; A Veillette
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

9.  Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation.

Authors:  J B Bolen; C J Thiele; M A Israel; W Yonemoto; L A Lipsich; J S Brugge
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

10.  Mapping of polyomavirus middle T domain that is responsible for AP-1 activation.

Authors:  M L Oliveira; T M Roberts; B J Druker; M C Armelin
Journal:  Oncogene       Date:  1998-06-11       Impact factor: 9.867

View more
  19 in total

1.  The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner.

Authors:  M Shanzer; I Ricardo-Lax; R Keshet; N Reuven; Y Shaul
Journal:  Oncogene       Date:  2014-11-03       Impact factor: 9.867

2.  Polyoma and SV40 proteins differentially regulate PP2A to activate distinct cellular signaling pathways involved in growth control.

Authors:  Pablo Rodriguez-Viciana; Crista Collins; Mike Fried
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-08       Impact factor: 11.205

Review 3.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

4.  Discovery of STL polyomavirus, a polyomavirus of ancestral recombinant origin that encodes a unique T antigen by alternative splicing.

Authors:  Efrem S Lim; Alejandro Reyes; Martin Antonio; Debasish Saha; Usman N Ikumapayi; Mitchell Adeyemi; O Colin Stine; Rebecca Skelton; Daniel C Brennan; Rajhab S Mkakosya; Mark J Manary; Jeffrey I Gordon; David Wang
Journal:  Virology       Date:  2012-12-29       Impact factor: 3.616

5.  Abl family tyrosine kinases regulate sialylated ganglioside receptors for polyomavirus.

Authors:  Alyson I Swimm; William Bornmann; Mengxi Jiang; Michael J Imperiale; Aron E Lukacher; Daniel Kalman
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

6.  Transgenic expression of polyomavirus middle T antigen in the mouse prostate gives rise to carcinoma.

Authors:  Sang Hyun Lee; Shidong Jia; Yanni Zhu; Tamara Utermark; Sabina Signoretti; Massimo Loda; Brian Schaffhausen; Thomas M Roberts
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

7.  Expression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression.

Authors:  Yingshe Zhao; Joerg Kumbrink; Bor-Tyh Lin; Amy H Bouton; Shi Yang; Paul A Toselli; Kathrin H Kirsch
Journal:  Carcinogenesis       Date:  2013-07-03       Impact factor: 4.944

8.  The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.

Authors:  Brian C Lewis; David S Klimstra; Harold E Varmus
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

9.  Oncoprotein GT198 vaccination delays tumor growth in MMTV-PyMT mice.

Authors:  Bhagelu R Achyut; Hao Zhang; Kartik Angara; Nahid F Mivechi; Ali S Arbab; Lan Ko
Journal:  Cancer Lett       Date:  2020-02-12       Impact factor: 8.679

10.  Activation of PyMT in beta cells induces irreversible hyperplasia, but oncogene-dependent acinar cell carcinomas when activated in pancreatic progenitors.

Authors:  Yi-Chieh Nancy Du; David S Klimstra; Harold Varmus
Journal:  PLoS One       Date:  2009-09-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.